ArticleEClinicalMedicine2022

Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial.

Cécile Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.